88 related articles for article (PubMed ID: 16607479)
1. Adherence to generic reverse transcriptase inhibitor-based antiretroviral medication at a Tertiary Center in North India.
Wanchu A; Kaur R; Bambery P; Singh S
AIDS Behav; 2007 Jan; 11(1):99-102. PubMed ID: 16607479
[TBL] [Abstract][Full Text] [Related]
2. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
[TBL] [Abstract][Full Text] [Related]
3. Effect of twice-daily nevirapine on adherence in HIV-1-infected patients: a randomized controlled study.
Parienti JJ; Massari V; Reliquet V; Chaillot F; Le Moal G; Arvieux C; Vabret A; Verdon R;
AIDS; 2007 Oct; 21(16):2217-22. PubMed ID: 18090049
[TBL] [Abstract][Full Text] [Related]
4. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
Cuzin L; Allavena C; Morlat P; Dellamonica P
AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976
[TBL] [Abstract][Full Text] [Related]
5. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.
Glass TR; De Geest S; Hirschel B; Battegay M; Furrer H; Covassini M; Vernazza PL; Bernasconi E; Rickenboch M; Weber R; Bucher HC;
Antivir Ther; 2008; 13(1):77-85. PubMed ID: 18389901
[TBL] [Abstract][Full Text] [Related]
6. Summaries for patients. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and patient outcomes.
Ann Intern Med; 2007 Apr; 146(8):I28. PubMed ID: 17438312
[No Abstract] [Full Text] [Related]
7. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya.
Talam NC; Gatongi P; Rotich J; Kimaiyo S
East Afr J Public Health; 2008 Aug; 5(2):74-8. PubMed ID: 19024414
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with suboptimal antiretroviral therapy adherence to dose, schedule, and dietary instructions.
Nilsson Schönnesson L; Williams ML; Ross MW; Bratt G; Keel B
AIDS Behav; 2007 Mar; 11(2):175-83. PubMed ID: 16927178
[TBL] [Abstract][Full Text] [Related]
9. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India.
Shah B; Walshe L; Saple DG; Mehta SH; Ramnani JP; Kharkar RD; Bollinger RC; Gupta A
Clin Infect Dis; 2007 May; 44(9):1235-44. PubMed ID: 17407045
[TBL] [Abstract][Full Text] [Related]
10. Validity of a stage of change instrument in assessing medication adherence in indigent patients with HIV infection.
Rathbun RC; Farmer KC; Lockhart SM; Stephens JR
Ann Pharmacother; 2007 Feb; 41(2):208-14. PubMed ID: 17213294
[TBL] [Abstract][Full Text] [Related]
11. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
Pujades-Rodríguez M; O'Brien D; Humblet P; Calmy A
AIDS; 2008 Jul; 22(11):1305-12. PubMed ID: 18580610
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 genotype after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and virological response after resumption of the same regimen.
Sungkanuparph S; Kiertiburanakul S; Apisarnthanarak A; Malathum K; Sathapatayavongs B
Int J STD AIDS; 2007 Dec; 18(12):832-4. PubMed ID: 18073016
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 drug resistance among untreated patients in India: Current status.
Pachamuthu B; Shanmugam S; Nagalingeswaran K; Solomon SS; Solomon S; Solomon S
J Postgrad Med; 2006; 52(3):183-6. PubMed ID: 16855318
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with accurate self-reported adherence to HIV antiretrovirals.
Kimmerling M; Wagner G; Ghosh-Dastidar B
Int J STD AIDS; 2003 Apr; 14(4):281-4. PubMed ID: 12716500
[TBL] [Abstract][Full Text] [Related]
16. The adherence to antiretroviral treatment evaluated from a hospital pharmacy: importance of the protease inhibitors pharmacological class.
Rubio M; Pédeboscq S; Ekouevi D; Zalabadi K; Chêne G; Bonarek M; Pometan JP
Int J STD AIDS; 2005 May; 16(5):379-82. PubMed ID: 15949070
[TBL] [Abstract][Full Text] [Related]
17. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
Gupta SB; Pujari SN; Joshi SR; Patel AK;
J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
[TBL] [Abstract][Full Text] [Related]
18. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
[TBL] [Abstract][Full Text] [Related]
19. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
[TBL] [Abstract][Full Text] [Related]
20. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
